Skip to content
Science
Our Scientific Approach
Publications
Pipeline
About Us
Leadership
Key Facts
Our Values
Contact Us
News
Press Releases
Media
Notice
Careers
Science
Our Scientific Approach
Publications
Pipeline
About Us
Leadership
Key Facts
Our Values
Contact Us
News
Press Releases
Media
Notice
Careers
Publications
Home
>
Science
>
Publications
Publications
All
AD
AD Biomarker
mRNA Vaccine
Diagnosis
AD
The role of microRNA-485 in neurodegenerative disease
Reviews in the Neurosciences, 07 Jul 2022
READ NOW
AD
Innate Immunity and Cell Death in Alzheimer's Disease
American Society for Neurochemistry, 20 Oct 2021
READ NOW
AD Biomarker
miRNAs as Therapeutic Tools in Alzheimer’s Disease
International Journal of Molecular Sciences, 01 Dec 2021
READ NOW
AD Biomarker
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
International Journal of Molecular Sciences, 04 Dec 2021
READ NOW
AD Biomarker
MicroRNAs as a Diagnostic Biomarker in Alzheimer’s Disease: Potential Roles and Characteristics
Global journal of intellectual & developmental disabilities, 14 Sep 2021
READ NOW
mRNA Vaccine
Influenza Viruses: Innate Immunity and mRNA Vaccines
Frontiers in Immunology, 31 Aug 2021
READ NOW
Diagnosis
Diagnostic and therapeutic biomarkers for Alzheimer’s disease in human‑derived platelets
Genes & Genomics, 12 Dec 2020
READ NOW
Posters & Presentations
Presentation
Role of miRNA in Neurodegenerative Disease
2022 The Korean Society Nonclinical Study (KSNS) / October, 2022
PRESENTATION
Presentation
Efficacy study and brain delivery in animal models of neurodegenerative disease (Rodent and NHP)
RNA Leaders World Congress / October, 2022
PRESENTATION
Presentation
Overcoming the Blood Brain Barrier for RNA therapeutics
2022 KoNECT-MOHW-MFDS INTERNATIONAL CONFERENCE / October, 2022
PRESENTATION
Poster
BMD-001, a nanoparticle containing miR-485-3p antisense oligonucleotide, blocks Alzheimer’s disease progression
Alzheimer’s Association International Conference (AAIC) / July, 2022
POSTER
Presentation
Overcoming the Blood–Brain Barrier for RNA therapeutics
RNA Leaders World Congress / March, 2022
VIDEO
Poster
Targeting microRNA-485-3p blocks Alzheimer's disease progression
Clinical Trials on Alzheimer's Disease (CTAD) / November, 2021
POSTER
VIDEO
Poster
BMD-001, a nanoparticle containing miR-485-3p antisense oligonucleotide, attenuates disease progression in Amyotrophic Lateral Sclerosis
PACTALS 2021 NAGOYA / September, 2021
POSTER
VIDEO
Poster
Targeting microRNA-485-3p blocks Alzheimer's disease progression
Alzheimer's Association International Conference (AAIC) / July, 2021
POSTER
VIDEO